ArticleBlood2007

High PR3 or ELA2 expression by CD34+ cells in advanced-phase chronic myeloid leukemia is associated with improved outcome following allogeneic stem cell transplantation and may improve PR1 peptide-driven graft-versus-leukemia effects.

Agnes S M Yong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.